Chronic Graft-Versus-Host Disease After Liver Transplantation: A Case Report

Basit Öğe Kaydı
dc.authoridIbrahim, Abeer M/0000-0002-2671-1623
dc.authoridAkbulut, Sami/0000-0002-6864-7711
dc.authoridErsan, Veysel/0000-0002-1510-0288
dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authoridYILMAZ, Mehmet/0000-0002-5710-5263
dc.authoridOzdemir, Fatih/0000-0003-0292-3602
dc.authoridÖZDEMİR, FATİH/0000-0003-0292-3602
dc.authorwosidIbrahim, Abeer M/F-1829-2019
dc.authorwosidAkbulut, Sami/L-9568-2014
dc.authorwosidErsan, Veysel/AAB-9595-2020
dc.authorwosidYilmaz, Sezai/ABI-2323-2020
dc.authorwosidYILMAZ, Mehmet/HKM-4739-2023
dc.authorwosidOzdemir, Fatih/ABH-2875-2020
dc.authorwosidYilmaz, Mehmet/AAF-6095-2021
dc.contributor.authorYilmaz, M.
dc.contributor.authorOzdemir, F.
dc.contributor.authorAkbulut, S.
dc.contributor.authorErsan, V.
dc.contributor.authorKoc, C.
dc.contributor.authorKoc, S.
dc.contributor.authorYilmaz, S.
dc.date.accessioned2024-08-04T20:36:02Z
dc.date.available2024-08-04T20:36:02Z
dc.date.issued2012
dc.departmentİnönü Üniversitesien_US
dc.description8th Congress of the Turkish-Transplantation-Centers-Coordination-Association (TTCCA) -- OCT 12-16, 2011 -- Antalya, TURKEYen_US
dc.description.abstractGraft-versus-host disease (GVHD) after orthotopic liver transplantation pun is a rare but significant complication, occuring in 1%-2% of cases with a mortality rate of 85%-90%. It occurs when donor passenger lymphocytes mount an alloreactive response against the host's histocompatibility antigens. It presents as fever, rash, and diarrhea with or without pancytopenia. Between March 2002 and September 2011, among 656 OLT patients 1 (0.15%) had acute GVHD. A biopsy at the 7th posttransplantation month revealed chronic GVHD. Consequently, in the cases that had fever, rash, and/or desquamation of the any part of body after liver transplantation, GVHD must be considered and skin biopsies must be planned for the diagnosis.en_US
dc.description.sponsorshipTurkish Transplantat Ctr Coordinat Assoc (TTCCA)en_US
dc.identifier.doi10.1016/j.transproceed.2012.05.036
dc.identifier.endpage1753en_US
dc.identifier.issn0041-1345
dc.identifier.issue6en_US
dc.identifier.pmid22841262en_US
dc.identifier.scopus2-s2.0-84864410097en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1751en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2012.05.036
dc.identifier.urihttps://hdl.handle.net/11616/95752
dc.identifier.volume44en_US
dc.identifier.wosWOS:000307433400077en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInfliximab Treatmenten_US
dc.subjectRecipienten_US
dc.subjectImmunosuppressionen_US
dc.subjectManagementen_US
dc.subjectWithdrawalen_US
dc.titleChronic Graft-Versus-Host Disease After Liver Transplantation: A Case Reporten_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu